KAYA17
www.kaya17.comKAYA17 is a Point-Of-Care Testing developer which has developed a 15-minute rapid Covid-19 saliva test. This test has an accuracy of 98% sensitivity and 100% specificity. Kaya17 is currently pending FDA approval for EUA of an Antigen test, and should hear back early 2021.
Read more
KAYA17 is a Point-Of-Care Testing developer which has developed a 15-minute rapid Covid-19 saliva test. This test has an accuracy of 98% sensitivity and 100% specificity. Kaya17 is currently pending FDA approval for EUA of an Antigen test, and should hear back early 2021.
Read more
Country
State
California
City (Headquarters)
Livermore
Industry
Employees
11-50
Social
Employees statistics
View all employeesPotential Decision Makers
Executive Chairman / Investor
Email ****** @****.comPhone (***) ****-****Scientist
Email ****** @****.comPhone (***) ****-****
Technologies
(17)
Reach decision makers at KAYA17
Free credits every month!
KAYA17 FAQ
Livermore, United States
Biotechnology Research
